Stroke is a leading cause of morbidity and mortality worldwide. Early recognition and prompt management are key to improving outcomes and reducing disability. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Early recognition of stroke is pivotal to prompt treatment. The acronym FAST (Face drooping, Arm weakness, Speech difficulties, Time to call emergency services) is a widely accepted tool for stroke recognition. However, other subtle signs such as sudden confusion, trouble seeing, difficulty walking, or severe headache with no known cause should also raise suspicion.
Once a stroke is suspected, immediate medical attention is necessary. Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) is the standard of care for ischemic strokes within 4.5 hours of symptom onset. Endovascular thrombectomy may be considered in certain patients with large vessel occlusion.
Neuroimaging plays a crucial role in differentiating ischemic from hemorrhagic stroke, which guides the treatment approach. Non-contrast CT scan is the initial imaging modality of choice due to its wide availability and speed. MRI may provide additional information in certain scenarios.
Once the acute phase is managed, focus shifts to secondary prevention to reduce the risk of recurrent stroke. This includes management of risk factors such as hypertension, diabetes, and hyperlipidemia, and initiation of antiplatelet therapy in ischemic stroke.
In conclusion, early recognition of stroke signs and prompt initiation of treatment can significantly improve patient outcomes. A holistic approach involving acute management, appropriate use of neuroimaging, and secondary prevention strategies is key to comprehensive stroke care. Continuous education and awareness among healthcare professionals about these aspects can greatly enhance stroke management.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation